Eli Lilly and Company (LLY) vs Mastercard Incorporated (MA)
See how Eli Lilly and Company and Mastercard Incorporated differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$589.31
NYSE
Mastercard Incorporated is the world’s second-largest payment processor, handling nearly $11 trillion in payment volume during 2025. The company operates in more than 200 countries and territories and processes transactions in over 150 currencies worldwide.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Mastercard IncorporatedMA
Market Cap$516.241B
Price$589.31
24h Change-1.01%
24h Volume$3.15M
Employees39,800
Shares Outstanding877,780,670
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
66.6%MA
33.4%Volume Share
Share of combined 24h volume
LLY
49.0%MA
51.0%24h Performance
Price change over last 24 hours
LLY
-1.52%MA
-1.01%Price Comparison
Eli Lilly and Company
Mastercard Incorporated